# Dexamethasone-implant for the Treatment of RVO

> **NCT01767545** · PHASE4 · COMPLETED · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 64 (actual)

## Conditions studied

- Macular Edema Caused by Retinal Vein Occlusion

## Interventions

- **DRUG:** Dexamethasone implant
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT01767545
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-01
- **Final completion:** 2012-02
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2013-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01767545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01767545, "Dexamethasone-implant for the Treatment of RVO". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01767545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*